Category - Pharma Industry News
Sanofi and Regeneron’s Libtayo trial stops early due to survival improvement
Sierra Oncology licenses myelofibrosis candidate from AstraZeneca
Pfizer, Flynn accused of charging the NHS ‘unfairly high prices’ for anti-epilepsy drug
Biogen/Eisai push for second approval in Alzheimer’s disease
Report finds reducing primary care antibiotic use ‘not enough’ to halt antimicrobial resistance
Reducing primary care antibiotic use may not be enough to counter antimicrobial resistance
SoftBank buys $5bn stake in Roche
Positive Phase III results for Valneva’s chikungunya vaccine